NASDAQ:PHIO Stock Quote
1.3100
+0.00 (0.00%)
Phio Pharmaceuticals Corp is a biotechnology company focused on the development of innovative therapies for cancer treatment
The company specializes in leveraging its proprietary delivery platform to enhance the effectiveness of immune-based therapies, particularly in the area of adoptive cell therapy. By utilizing their unique technology, Phio aims to create treatments that can empower the body’s immune system to better target and destroy cancer cells, ultimately improving patient outcomes and offering new hope in the fight against various types of cancer.
